Key efficacy outcomes of interest included HF hospitalization, all‐cause mortality, left ventricular ejection fraction (LVEF), N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), together with New York Heart Association (NYHA) functional class. The gene discussed is NPPB; the disease is hydrops fetalis.